If you look at my chart on SPPI you can se it dosent look very well. We need to have good CUP data anytime soon. The support level is far away and the resitance is on the two green lines. But can we break the two green lines, the sky’s the limit.

About Investor1989

Investor in stocks in about 5 years with some very good profits. Focusing on Biotech and Value stocks. Active investor...


3 Responses to Spectrum Chart

  1. Pumpa says:

    Thankyou for your answer, I belive that it is in us $…and I know that it never goes as you wish in biotech….

  2. Investor1989 says:

    This is a tuff question. It depends on Apaziquone and Belinostat data. I can talk about what i expect if everything go straight trough. But as you know, it never does this in biotech.

    If Apaziquone and Belinostat are good and approved in 2013, and Zevalin sales rises with Fusilev. I can se 50 in 2013, 100 in 2014 and maybe 200 in 2015. If Belinostat in CUP get approved after this phase II or gets significant off label sales it can be better. but again, its blueskye

  3. Pumpa says:

    Good work, what is your target in 1,2 and 3 years.

Leave a Reply

Your email address will not be published. Required fields are marked *

Set your Twitter account name in your settings to use the TwitterBar Section.